Abstracts tagged "socio-economic inequities and socioeconomic factors"

Abstract Number: 268 • 2019 ACR/ARP Annual Meeting
LARS Study: Latin American Rheumatologist Survey
Genessis Maldonado¹, Maria Intriago ¹, Enrique Soriano ², Letty Moreno ³ and Carlos Rios ¹, ¹Universidad Espiritu Santo, Guayaquil, Ecuador, ²Rheumatology Section, Internal Medicine Service, Hospital Italiano de Buenos Aires, Argentina., Buenos Aires, Buenos Aires, Argentina, ³Centro de Reumatología y Rehabilitación, Guayaquil, Ecuador
Background/Purpose: :Currently, Latin America does not have detailed information of rheumatologists in the region based on: education, working conditions, productivity, distribution of time between work…
Abstract Number: 689 • 2015 ACR/ARHP Annual Meeting
Are Individual or Country Level Socio-Economic Determinants Related to Disease Activity and Self-Reported Physical Function in Patients with Spondyloarthritis – Results from Multi-National Cross-Sectional Study Comospa
Polina Putrik¹, Sofia Ramiro², Andras Keszei³, Maxime Dougados⁴, Anna Moltó⁵, Désirée van der Heijde², Robert B.M. Landewé⁶ and Annelies Boonen⁷, ¹Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, ²Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ³Epidemiology, Maastricht University, Maastricht, Netherlands, ⁴Université Paris René Descartes and Hôpital Cochin, Paris, France, ⁵Paris Descartes University, Rheumatology Department, Cochin Hospital, AP-HP. INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité,, Paris, France, ⁶Department of Rheumatology, Amsterdam Rheumatology Center, Amsterdam, Netherlands, ⁷Maastricht University Medical Center, Maastricht, Netherlands
Background/Purpose: In RA, previous studies observed inequalities across countries as well as individual level socio-economic factors, and unequal uptake of biologic DMARDs (bDMARDs) played an…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].